6.38
-0.30
(-4.49%)
At close: January 10 at 4:00:01 PM EST
Environment, Social and Governance (ESG) Risk Ratings
Total ESG Risk Score
33.3
ESG Risk Score for Peers
| Name | Total ESG Risk score | E | S | G |
|---|---|---|---|---|
| XFOR X4 Pharmaceuticals, Inc. | 33 | -- | -- | -- |
| 3NK.MU Alphamab Oncology R | 33 | -- | -- | -- |
| ABVX Abivax SA | 33 | -- | -- | -- |
| HTSUF HISAMITSU PHARMACEUTICAL CO INC | 33 | 3 | 19 | 11 |
| ASPHF ASCENTAGE PHARMA GROUP INTL | 33 | -- | -- | -- |
Controversy Level Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies are rated on a scale from one to five with five denoting the most serious controversies with the largest potential impact.
Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies are rated on a scale from one to five with five denoting the most serious controversies with the largest potential impact.
ESG data provided by Sustainalytics, Inc. Last Updated on 1/2025
ABVX
Category Average
N/A None Controversy Level
None 4 Severe
-- ABVX
0.5 Category Average
Product Involvement Areas Flags a company’s involvement in products, services and business activities commonly used for screening purposes.
Flags a company’s involvement in products, services and business activities commonly used for screening purposes.
| Products and Activities | Significant Involvement |
|---|---|
| Alcoholic Beverages | No |
| Adult Entertainment | No |
| Gambling | No |
| Tobacco Products | No |
| Animal Testing | Yes |
| Fur and Specialty Leather | No |
| Controversial Weapons | No |
| Small Arms | No |
| Catholic Values | No |
| GMO | No |
| Military Contracting | No |
| Pesticides | No |
| Thermal Coal | No |
| Palm Oil | No |
Related Tickers
SYRE Spyre Therapeutics, Inc.
22.46
-6.49%
MEDCL.PA MedinCell S.A.
16.48
-2.25%
MLTX MoonLake Immunotherapeutics
46.32
-3.85%
ELVN Enliven Therapeutics, Inc.
21.74
-9.98%
PHVS Pharvaris N.V.
17.80
-3.99%
ANAB AnaptysBio, Inc.
14.21
-1.04%
AVTE Aerovate Therapeutics, Inc.
2.5500
-3.41%
RAPP Rapport Therapeutics, Inc.
14.81
-11.26%
BIOA-B.ST BioArctic AB (publ)
206.80
+1.08%
I54.F Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
0.8150
+3.16%